J Korean Soc Transplant.  2006 Dec;20(2):143-148.

Proliferation Signal Inhibitors: Sirolimus and Everolimus

Affiliations
  • 1Department of Internal Medicine, BongSeng Hospital, Busan, Korea. kidney119@hotmail.com

Abstract

Proliferation signal inhibitors are a new class of immunosuppressant. They inhibit the mammalian target of rapamycin and blocks the cell cycle of various cell types, including T and B lymphocytes. PSI is used in renal transplantation as a maintenance immunosuppressant. The benefit of this drug in some immunologic and malignant disease is currently under being focused. Reports of synergism with cyclosporine and tacrolimus in preclinical and clinical studies, avoidance of nephrotoxicity and possible treatment or prevention of chronic allograft nephropathy are leading to high expectations for this new class of immunosuppressant. This review summarizes preclinical and clinical results published to date and evaluates the future value of PSI for renal transplantation.

Keyword

Renal transplantation; Proliferation signal inhibitor; Nephrotoxicity
Full Text Links
  • JKSTN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr